The Treatment Effect of an ACE-Inhibitor Based Regimen with Perindopril in Relation to Beta-Blocker use in 29,463 Patients with Vascular Disease: a Combined Analysis of Individual Data of ADVANCE, EUROPA and PROGRESS Trials

INTRODUCTION: In everyday practice, angiotensin converting enzyme inhibitors and beta-blockers are cornerstone treatments in patients with (cardio-)vascular disease. Clear data that evaluate the effects of the combination of these agents on morbidity and mortality are lacking. METHODS: In this retro...

Descripción completa

Detalles Bibliográficos
Autores principales: Brugts, J. J., Bertrand, M., Remme, W., Ferrari, R., Fox, K., MacMahon, S., Chalmers, J., Simoons, M. L., Boersma, E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5607906/
https://www.ncbi.nlm.nih.gov/pubmed/28856537
http://dx.doi.org/10.1007/s10557-017-6747-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5607906/
https://www.ncbi.nlm.nih.gov/pubmed/28856537
http://dx.doi.org/10.1007/s10557-017-6747-9

Ejemplares similares